Company & Sponsor Intelligence

Huashan Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials4

Recruiting1

Completed1

Countries1

Therapeutic footprint

movement_disordersneuromuscularother_neurologystroke

Indexed studies

NCT03898635Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous Meningitis
other_neurology · ChinaUNKNOWN

NCT04367116The Study to Evaluate the Safety and Efficacy of Spinal Cord Stimulation on Progressive Supranuclear Palsy
movement_disorders · ChinaNA

NCT07146425Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
neuromuscular · ChinaRECRUITING

NCT04086147CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase
stroke · ChinaPHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →